- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
Policy Recommendations Nevada
2020-21 Improvements and Recommendations
In the 2020 legislative session, Nevada lawmakers passed AB341 which, among other legal reforms, called for the creation of a new committee made up of patients and industry stakeholders that would weigh in on regulatory affairs. In July 2020, the first meeting of Nevada’s new Cannabis Advisory Committee was held. The committee will break into several subcommittees that will approach different regulatory issues faced by Nevada’s cannabis program including Social Equity, Diversity, and Inclusion, Public Health, Public Safety, and Market Stability.
Per Governor Steve Sisolak’s Emergency Directive #044, decisions on COVID-19 mitigation measures transitioned to local authority on May 1, 2021. In May, Governor Sisolak signed a bill making curbside pickup permanent. An additional COVID emergency measure where regulators had extended all patient registrations through June 2021 was not renewed.
In 2022, Nevada lawmakers looking to improve their grade should focus on expanding the protections the state provides to patients to cover housing and parental rights. The new Cannabis Advisory Committee should also move to abolish the qualifying condition list, instead allowing medical cannabis to be recommended for any condition.
Share